Protalix BioTherapeutics
PLX
#8434
Rank
NZ$0.30 B
Marketcap
$4.17
Share price
1.50%
Change (1 day)
62.50%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$12.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$45.66 Million. In 2023 the company made an earning of NZ$20.72 Million, an increase over its 2022 earnings that were of -NZ$20.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$12.83 Million-161.86%
2023 NZ$20.72 M-199.05%
2022 -NZ$20.93 Million-40.38%
2021 -NZ$35.1 Million-732.31%
2020 NZ$5.55 M-130.53%
2019 -NZ$18.18 Million189.85%
2018 -NZ$6.28 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.64 Million-32.37%
2015 -NZ$48.27 Million10.11%
2014 -NZ$43.83 Million-7.59%
2013 -NZ$47.43 Million
2011 -NZ$54.93 Million-19.39%
2010 -NZ$68.14 Million20.87%
2009 -NZ$56.37 Million32.26%
2008 -NZ$42.62 Million-5.46%
2007 -NZ$45.08 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.69 Million1.03%
2000 -NZ$0.68 Million-53.22%
1999 -NZ$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.13 Billion 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.15 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.24 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.74 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel